Navigation Links
Macugen drug for treating degenerative eye disease

The drug Macugen is found to be effective in treating wet age related macular degeneration disease which is a progressive disease// of the macula. Wet age related macular degeneration is caused due to a chronic degenerative disease of the macula region of the eye, macula is present in the retina which is responsible for proper eye sight.

The degenerative disease is caused by the growth of abnormal blood vessel beneath the macula which leads to severe bleeding and accumulation of fluid in retina leading to a condition called Choroidal neovascularization. The new drug Macugen, which is manufactured by Pfizer and OSI Pharmaceuticals, is found to be very effective in treating this degenerative disease by preserving the visual integrity of the macula, the drug is found to stop bleeding and accumulation of fluid in the retina and is found to be very effective than other treatment procedures offered to cure eye disease.


'"/>




Page: 1

Related medicine news :

1. Eye Drug Macugen Shows Allergic Reactions
2. Gene Therapy shows promise in treating Hemophilia
3. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
4. Diuretics are better for treating blood pressure problems than newer medicines
5. A ray of hope in treating blindness and other eye disorders
6. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
7. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
8. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
9. Lower doses of oral contraceptives helpful in treating acne
10. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
11. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
Post Your Comments:
(Date:10/13/2008)...First Chewable Sustained Energy Enhancing Suppleme...EXPAND, the US based,nutritional supplement manufa...ality supplements., Glyc,n Go, is the first and o... (GPLC) supplement, and the effects that it has on... of athletes and trainers,around the globe., In c...
(Date:10/13/2008)...ii, Oct. 13 /PRNewswire/ -- NeoVista, Inc., presen...s novel epiretinal,brachytherapy device on choroid...can Society of Retina Specialist,s (ASRS) 26th Ann...Brown, MD, F.A.C.S., of The Methodist,Hospital, Ho...n both,angiography and ocular coherence tomography...
(Date:10/13/2008)... AtlantaJobs.com and numerous newspaper... www.AtlantaJobs.com . AtlantaJobs.com is the new... employers and jobseekers in the metro Atlanta are...October 13, 2008 -- AtlantaJobs.com and numerous...launch of AtlantaJobs.com is the newest online j...
(Date:10/12/2008)...October 13, 2008 Five neonatology fellows have be...nd research in the area of follow-up care of the p...Program. The grants, which underscore MedImmune,s ...medicine, will provide each recipient,s institutio...unding. The five recipients were acknowledged on S...
Breaking Medicine News(10 mins):Health News:NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting 2Health News:NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting 3Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2Health News:MedImmune grants 5 new fellowships to help expand premature infant follow-up care research 2
...oes not advocate more power, freedom or equal soci...dary skincare queen has inspired a legion of young...dependence in a culture that for millennia has pre...eauty (NB)' cosmetics and skincare empire, which s...
...the country, Prime Minister Manmohan Singh will co...t Council (NDC) to discuss disease control and pub...he implementation of the National Rural Health Mis...nts to pay adequate attention to healthcare issues...
...e hormone previously found to produce a feeling of...o may help curb binge eating and the desire to eat...thetic form of amylin, a satiety hormone produced ...which also produce insulin. Pramlintide treatmen...
...ity Medical Center say they are moving closer to u...aria has become resistant to drug treatment in th...icially construct, and then express in yeast, a pr...h resistance. The gene they laboriously construct...
Other Medicine News:Health News:Taiwan Skincare Empire Built on 'Natural Beauty' 2Health News:Taiwan Skincare Empire Built on 'Natural Beauty' 3Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 2Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 3Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 4Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 5Health News:New Insights into Antimalarial Drug Resistance 2Health News:New Insights into Antimalarial Drug Resistance 3Health News:New Insights into Antimalarial Drug Resistance 4
(Date:10/9/2008)...ts Expected in November 2008, BOTHELL, Wash., Oct...Amex: DDD ) announced today the completion of pat...ree pivotal trials to evaluate the safety and,effi...e (ER) ibuprofen for,the over-the-counter (OTC) ma...ts from this pivotal trial in November 2008. Ibupr...
(Date:10/8/2008)...Inform Treatments for Spinal Cord, Other Nerve,Inj...ire/ -- A protein that enables,nerve cells to comm...lling,the developing nervous system. Research into...m among nerve cells may provide a basis for eventu...their nervous system,including spinal cord injury...
(Date:10/8/2008)...Potency of Poly-ICR as Vaccine Adjuvant, SAN DIEG...maceuticals,Corporation (TSX: NVN) today presented...proprietary Toll-like Receptor 3 agonist, Poly IC-...gress 2008 in Lyon, France.,Study results demonstr...eting the Toll-like Receptor 3 (TLR3) pathway. Dat...
(Date:10/7/2008)...y of new device for detecting polyps that can be ...RLANDO, Fla., Oct. 7 /- At the Americ...eeting in Orlando (ACG 2008), renowned,gastroenter...a,multi-institutional clinical study that evaluate...a new device that is designed to improve the abili...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference 7403 1Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference 7403 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 1Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 3Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 25916 1Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 25916 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 1TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 3
...inocycline Showed Substantial,Reduction of Disease...ing Multiple Sclerosis , Combination Treatment Wit... Well Tolerated , KANSAS CITY, Mo, May 4, 2007 - N...ed that a combination of Copaxone,(glatiramer acet...cycline reduced T1 Gadolinium (Gd)-enhancing lesio...
...E)--May 4, 2007 - New data from a,randomized, doub...NE(R) (glatiramer acetate injection) along with th...m (Gd)-enhancing lesions,of the brain by 63 percen...ting multiple sclerosis (RRMS), as measured by,mag...eceiving,COPAXONE(R) alone. Additionally, the nine...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
The Clearview hCG Combo with Reference Line Test for the rapid detection of human chorionic gonadotropin (hCG) in urine or serum specimens. This test kit is used to obtain visual, qualitative result
...ty loupes available at manufacturer-direct prices...n, combining superior quality withunmatched custom...ximum comfort, SheerVision loupes are the clear ch...h a professional and a fashion statement by wearin...
Medicine Products: